Fayez Sarofim & CO Johnson & Johnson Transaction History

Fayez Sarofim & CO

$33 Billion
Q1 2024

A detailed history of Fayez Sarofim & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Fayez Sarofim & CO holds 974,896 shares of JNJ stock, worth $142 Million. This represents 0.47% of its overall portfolio holdings.

Number of Shares

974,896

Previous 1,038,254 6.1%

Holding current value

$142 Million

Previous $163 Million 5.23%

% of portfolio

0.47%

Previous 0.52%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	SELL	$155.22 - $162.74 $9.83 Million - $10.3 Million	-63,358 Reduced 6.1%	974,896 $154 Million
Q4 2023 Feb 14, 2024	SELL	$145.6 - $158.88 $37.4 Million - $40.9 Million	-257,154 Reduced 19.85%	1,038,254 $163 Million
Q3 2023 Nov 14, 2023	SELL	$155.75 - $174.48 $63.4 Million - $71 Million	-406,745 Reduced 23.9%	1,295,408 $202 Million
Q2 2023 Aug 14, 2023	SELL	$154.35 - $166.11 $51.6 Million - $55.5 Million	-334,115 Reduced 16.41%	1,702,153 $282 Million
Q1 2023 May 11, 2023	SELL	$151.05 - $180.26 $52.6 Million - $62.8 Million	-348,190 Reduced 14.6%	2,036,268 $316 Million

Q4 2022 Feb 13, 2023	SELL	$160.2 - $179.79 $3.75 Million - $4.21 Million	-23,397 Reduced 0.97%	2,384,458 $421 Million
Q3 2022 Nov 14, 2022	BUY	$161.33 - $179.52 $392,515 - $436,772	2,433 Added 0.1%	2,407,855 $393 Million
Q2 2022 Aug 12, 2022	BUY	$168.19 - $186.01 $25.6 Million - $28.4 Million	152,427 Added 6.77%	2,405,422 $427 Million
Q1 2022 May 16, 2022	BUY	$158.14 - $179.59 $21.6 Million - $24.6 Million	136,734 Added 6.46%	2,252,995 $399 Million
Q4 2021 Feb 11, 2022	BUY	$155.93 - $173.01 $9.54 Million - $10.6 Million	61,161 Added 2.98%	2,116,261 $362 Million
Q3 2021 Nov 15, 2021	SELL	$161.5 - $179.47 $1.46 Million - $1.62 Million	-9,045 Reduced 0.44%	2,055,100 $332 Million
Q2 2021 Aug 13, 2021	SELL	$159.48 - $171.07 $2.23 Million - $2.39 Million	-13,982 Reduced 0.67%	2,064,145 $340 Million
Q1 2021 May 13, 2021	SELL	$153.07 - $170.48 $3.3 Million - $3.67 Million	-21,552 Reduced 1.03%	2,078,127 $342 Million
Q4 2020 Feb 11, 2021	SELL	$137.11 - $157.38 $2.42 Million - $2.78 Million	-17,656 Reduced 0.83%	2,099,679 $330 Million
Q3 2020 Nov 13, 2020	SELL	$140.38 - $153.83 $1.34 Million - $1.47 Million	-9,530 Reduced 0.45%	2,117,335 $315 Million
Q2 2020 Aug 11, 2020	BUY	$128.81 - $155.51 $19.8 Million - $23.9 Million	153,792 Added 7.79%	2,126,865 $299 Million
Q1 2020 May 12, 2020	SELL	$111.14 - $153.99 $12.3 Million - $17.1 Million	-110,949 Reduced 5.32%	1,973,073 $259 Million
Q4 2019 Feb 14, 2020	BUY	$127.5 - $146.44 $143,820 - $165,184	1,128 Added 0.05%	2,084,022 $304 Million
Q3 2019 Nov 13, 2019	BUY	$126.95 - $142.14 $429,471 - $480,859	3,383 Added 0.16%	2,082,894 $269 Million
Q2 2019 Aug 09, 2019	SELL	$131.15 - $144.24 $12.3 Million - $13.5 Million	-93,874 Reduced 4.32%	2,079,511 $290 Million
Q1 2019 May 14, 2019	BUY	$125.72 - $139.79 $3.48 Million - $3.87 Million	27,659 Added 1.29%	2,173,385 $304 Million
Q4 2018 Feb 13, 2019	SELL	$122.84 - $147.84 $1.68 Million - $2.02 Million	-13,640 Reduced 0.63%	2,145,726 $277 Million
Q3 2018 Nov 14, 2018	BUY	$121.58 - $142.88 $1.72 Million - $2.02 Million	14,121 Added 0.66%	2,159,366 $298 Million
Q2 2018 Aug 14, 2018	SELL	$119.4 - $131.76 $4.01 Million - $4.43 Million	-33,602 Reduced 1.54%	2,145,245 $260 Million
Q1 2018 May 10, 2018	SELL	$125.1 - $148.14 $850,179 - $1.01 Million	-6,796 Reduced 0.31%	2,178,847 $279 Million
Q4 2017 Feb 13, 2018	SELL	$131.22 - $143.62 $1.5 Million - $1.64 Million	-11,428 Reduced 0.52%	2,185,643 $305 Million
Q3 2017 Nov 08, 2017	BUY	$129.47 - $135.38 $284 Million - $297 Million	2,197,071	2,197,071 $286 Million

Others Institutions Holding JNJ

# of Institutions

4,146

Shares Held

1.64B

Call Options Held

15.1M

Put Options Held

12.1M

View Full List

About JOHNSON & JOHNSON

Ticker JNJ
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,614,479,872
Market Cap $382B
Description
Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...

More about JNJ

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fayez Sarofim & CO, based on Form 13F filings with the SEC.

News

Stay updated on Fayez Sarofim & CO with notifications on news.

Account